Global Custom Market Research Reports Provider Company

phone

Global Blood Therapeutics Inc (GBT) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The companys lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease (SCD) is in Phase II clinical trial statge. Its GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell sickling for the treatment of SCD. GBTs pipeline also includes an oral kallikrein inhibitor to prevent hereditary angioedema (HAE) attacks. The company also develops therapies which are in preclinical and preliminary clinical stage for the treatment of for acute and chronic hypoxemic pulmonary disorders such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS). It offers chemical and biological mechanisms of blood-based disorders. GBT is headquartered in South San Francisco, California, the US.

Global Blood Therapeutics Inc Key Recent Developments

Feb 27,2018: GBT Reports Fourth Quarter and Year-End 2017 Financial Results
Dec 22,2017: GBT Appoints Wendy L. Yarno to Board of Directors
Nov 02,2017: Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2017 Financial Results
Sep 06,2017: Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at Annual Sickle Cell Disease Therapeutics Conference
Aug 07,2017: Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results

This comprehensive SWOT profile of Global Blood Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Global Blood Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Global Blood Therapeutics Inc - Key Information
Global Blood Therapeutics Inc - Overview
Global Blood Therapeutics Inc - Key Employees
Global Blood Therapeutics Inc - Key Employee Biographies
Global Blood Therapeutics Inc - Key Operational Heads
Global Blood Therapeutics Inc - Major Products and Services
Global Blood Therapeutics Inc - History
Global Blood Therapeutics Inc - Company Statement
Global Blood Therapeutics Inc - Locations And Subsidiaries
Global Blood Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Global Blood Therapeutics Inc - Business Description
Global Blood Therapeutics Inc - Corporate Strategy
Global Blood Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Global Blood Therapeutics Inc - Strengths
Global Blood Therapeutics Inc - Weaknesses
Global Blood Therapeutics Inc - Opportunities
Global Blood Therapeutics Inc - Threats
Global Blood Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Global Blood Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Global Blood Therapeutics Inc, Key Information
Global Blood Therapeutics Inc, Key Ratios
Global Blood Therapeutics Inc, Share Data
Global Blood Therapeutics Inc, Major Products and Services
Global Blood Therapeutics Inc, History
Global Blood Therapeutics Inc, Key Employees
Global Blood Therapeutics Inc, Key Employee Biographies
Global Blood Therapeutics Inc, Key Operational Heads
Global Blood Therapeutics Inc, Other Locations
Global Blood Therapeutics Inc, Subsidiaries
Global Blood Therapeutics Inc, Key Manufacturing facilities
Global Blood Therapeutics Inc, Key Competitors
Global Blood Therapeutics Inc, SWOT Analysis
Global Blood Therapeutics Inc, Ratios based on current share price
Global Blood Therapeutics Inc, Annual Ratios
Global Blood Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Global Blood Therapeutics Inc, Performance Chart
Global Blood Therapeutics Inc, Ratio Charts

Lysosomal storage diseases are a rare group of genetic disorders that resulted from the malfunctioning or lack of lysosomal enzymes. Tay-Sachs disease was the first lysosomal storage disorder (LSD). It

View Report

"The report titled “Global Neuromodulation Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the Neuromodulation Market globally. "

View Report

Dry Eye Syndrome: Global Drug Forecast and Market Analysis to 2026 Dry Eye Syndrome (DES) is a multifactorial disease of the tears and ocular surface that causes ocular discomfort, visual disturbances,

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports